GSK Reverses Decade of Denial: Paxil Triggered Suicide in Adults
GlaxoSmithKline Reverses Decade of Denial: in Clinical Trials Paxil Triggered Significantly More Suicide Attempts in Adults than Placebo
Yale-Lilly Experiment: Adolescents Rx Toxic Drug for Presumed Mental Illness They Do Not Have
When the Times refers to an experiment as "bold and controversial" the reporter is sanitizing the fact that the experiment is UNETHICAL—it violates medicine’s cardinal rule "First, do no harm."
Glaxo denies “disease mongering”_Selling Bipolar questioned_PLoS
Under the influence of pharmaceutical companies, physicians anhd drug companies engage in "disease mongering." Below is a critique of Dr. David Healy’s essay: Dr. Nassir Ghaemi who argues for the legitimacy of bipolar diagnosis.
What’s wrong with American medicine?
The answer given by Dr. Joseph Britto, a pediatric intensive care physician, hits the nail on the head: "Unlike pilots, doctors don’t go down with their planes."
Psychiatry’s Diagnostic Manual Under Drug Industry Influence
The undisclosed financial relationships between drug manufacturers and psychiatry’s leading "authorities" who determine what constitutes a “mental disorder” have been exposed.
Disease Mongering_Conference / PLoS Special Issue
"Are we becoming patients for profit? That is the question knowledgeable observers are asking.
Comparison of Suicide Rates in Treated Schizophrenia Patients Found 20-Fold Increase
An analysis published in the current issue of the British J of Psychiatry (BJP) of the suicide rate among schizophrenia patients treated at the same hospital in North Wales (UK) before psychotropic drugs and patients treated (in and out of hospital) with neuroleptics and /or atypical antipsychotics, found a 20-fold increase in the suicide rate since use of psychotropic drugs.
Antipsychotic Drugs are Killing patients_Brit J Psychiatry
A major 17-year follow up study published in the British Journal of Psychiatry [1] found a 2.84 times (95% CI 2.06–3.90) increased risk of mortality in people with schizophrenia compared to those not so diagnosed, and with each addition of a neuroleptic (antipsychotic) drug, the risk increased another 2.50.
NIMH-funded antidepression drug efficacy / safety studies_What do they prove?
Two studies purporting to report “new encouraging” findings about the efficacy and safety of antidepressants—as tested in the “real world”—were published on Sunday by The American Journal of Psychiatry with an accompanying editorial by Dr. Thomas Insel, director of these studies’ funding agency, the National Institute of Mental Health.
Gov Accountability Project Creates "FactSquad" on Rx Drugs
Gov Accountability Project Creates “FactSquad” on Rx Drugs December 11, 2005 In the wake of the credibility crisis public trust in the safety of FDA-approved prescription drugs is eroded. The Government Accounability Project (GAP) has established a “Fact Squad” to challenge poor performance; in particular, FDA’s failure to protect the…
Ethics, Conflict of Interest, first ever public response by David Healy, MD, to James Coyne, PhD, attack in AJOB
The Columbia lecture was originally scheduled as a debate between David Healy, MD and James Coyne, PhD. The debate did not take place, and Dr. Coyne subsequently lectured in Rutgers the following week. The lecture covered the main points Dr. Coyne makes in the e-mail below. Dr. Healy’s response follows….
Antidepressants & Suicide-Related Risks: 9/14/04 AHRP Press Briefing
AHRP Press Briefing September 14, 2004 Antidepressants and Suicide-Related Risks for Children Scientists’ Presentations at AHRP Press Briefing in Conjunction with FDA Hearings: Peter Mansfield, MD, University of Adelaide (Australia), Director of Healthy Skepticism discussed the illusion of potency in light of the meta-analyses in the British Medical Journal (which…